Committee advances non‑opioid parity bill to Appropriations after removing Medicaid and state plans
Senate Bill 6, which would require insurers and Medicaid to treat FDA‑approved non‑opioid prescription pain drugs with no greater administrative burden or cost‑sharing than opioids, was advanced to Appropriations as amended. Sponsors removed Medicaid and state plans from the bill citing fiscal concerns; the committee approved the referral 6–1.
The full story
Sponsors presented Senate Bill 6 as a patient‑safety and parity measure to ensure non‑opioid prescription pain drugs are as accessible as opioids, arguing that coverage design and administrative hurdles have inadvertently favored opioids. "This bill is about parity and patient and provider choice," a sponsor said during opening remarks.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in